Leal Therapeutics
Develops neuro-metabolic therapeutics for schizophrenia and ALS
$30MSeries A
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops neuro-metabolic therapeutics for schizophrenia and ALS
Clinical-stage biopharma developing injectable therapies for hair loss
Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease
Develops durable protein therapeutics via gene therapy for chronic diseases
Developing best-in-class radiopharmaceuticals for cancer treatment
Develops lead-212 targeted alpha therapies to treat cancer
Develops small molecule therapies to degrade protein aggregates in neurodegenerative diseases
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
Develops precision immunoregulatory medicines based on tissue Treg biology
Develops regenerative biologics to restore tissue function